BNP Paribas Asset Management
TARS icon

BNP Paribas Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

BNP Paribas Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6K Sell
471
-82
-15% -$5.24K ﹤0.01% 1944
2026
Q1 		$38.8K Buy
553
+120
+28% +$8.38K ﹤0.01% 1827
2025
Q4 		$35K Buy
433
+131
+43% +$9.78K ﹤0.01% 1779
2025
Q3 		$18K Sell
302
-12
-4% -$591 ﹤0.01% 1441
2025
Q2 		$13K Buy
+314
New +$14.1K ﹤0.01% 1690

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BNP Paribas Asset Management's TARS Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Tarsus Pharmaceuticals (TARS) stake by 15% in Q2 2026, selling an estimated $5.24K and leaving 471 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

BNP Paribas Asset Management first reported a position in TARS in Q2 2025 and has held it in 5 quarters since. The position peaked at $38.8K in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • BNP Paribas Asset Management held 471 shares of Tarsus Pharmaceuticals worth $29.6K as of Q2 2026.
  • BNP Paribas Asset Management sold 82 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $5.24K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1944 holding.
  • BNP Paribas Asset Management first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Tarsus Pharmaceuticals position peaked at $38.8K in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.